Alprolix Market: Growth Trends and Future Outlook

adicionou um novo artigo Outro

2026-03-21 09:08:59 -

The Alprolix Market is gaining traction due to the increasing prevalence of hemophilia B, advancements in biologic therapies, and growing awareness of rare bleeding disorders. Alprolix is a recombinant factor IX therapy used for the treatment and prevention of bleeding episodes in patients with hemophilia B. It is designed with extended half-life properties, allowing for less frequent...

0 Comentários 0 Compartilhamentos 146 Visualizações 0 Anterior